Hikma Pharmaceuticals’ Post

In reimagining healthcare, how should #innovation readiness be transformed to fully unlock the value of emerging #health technologies? Tori Brown, President of North Asia-Pacific and General Manager of ANZ at Eli Lilly Australia & New Zealand joined me on this series in challenging the status quo and sharing her vision of innovation readiness in the next 10-15 years. "Innovation readiness means that by the time a product or technology hits the market, the market and patients are available to use it right away. As industry, we really need to think about the big picture of what could be...," Tori says. "As individuals and as companies, we need to be reimagining what can happen in the healthcare spaces that we invest. And we can't expect politicians, doctors or anybody else to do it for us." Link to full podcast: https://lnkd.in/gFjiy2cj #elililly #lilly #pharma #pharmaceuticals #healthcare Eli Lilly and Company

Rx Revolution: Pharma Leaders Choose Prescription Growth in LinkedIn Poll I recently threw out a question on LinkedIn for all pharma leaders: prescription growth or value sales? And guess what? The results were clear! Nearly 90% of respondents said prescription growth is king! This totally aligns with what my mentor, the amazing Prof. Chitta Mitra, always stressed: "Grow prescriptions and the value will follow." Here's the thing: a healthy pharma brand thrives on prescriptions generated. It's the lifeblood of any pharma organization. So keep up the fantastic work, pharma leaders! Focus on getting those prescriptions up, and your brands and companies will be unstoppable! Vivek

Wrote in a comment.. Vivek Hattangadi ji Whatever you write, we'll accept because you do not aim to prove something to someone. You're my legendary editor for my very first article in Medicine Point. However, there are also some painful and harsh experiences about the era of prescription market. Now, this market operates in various forms such as generics (No prescription) - B2B commercial (No prescription) - Scheme & Push model. Branded (leverage the brand name but selling it to other Indian companies) eg Voveran People are still paying high price for its Innovation but company has washed it hands long back Sunil Malkany is the living proof because he promoted it in CIBA. Now it's Dr Reddy's brand. So, either the retailer, hospital, doctor's assistance teams, or the doctor themselves... Will no respect the prescription that they wrote to the patient. They will inform companies that they continue prescribing what they committed to with certain companies and avail benefits but the patient will receive brands available off their shelves then there is new catch company say why don't you buy and sell at your retail counter.... Dr get one more opportunity annual package is on plus now, new negotiations for purchase ie buy retail qty at distributor price. Abraham Moses jayant devadiga Devendra Mehta Sandeep Mohe Prakash S Kayal Sunil Malkany

Bringing new medicines to people who need them isn’t just about the latest technology. It’s about having a sustainable manufacturing and supply infrastructure, with diverse and talented people working together.      In the latest episode of our Transforming Health series, Leila Schwery (Bou-Diab) from our manufacturing and technical operations team discusses Switzerland’s unique ecosystem of world-leading pharmaceutical capabilities, and what other countries could learn from its model.     Listen here to learn more: https://bit.ly/3zIcWFm.

When launching a pharma brand, the pressure to succeed is immense. 😰 But what does this mean, achieving an excellent brand launch ❓ In this insightful video Jo Lopez, CELforPharma faculty member, launch expert and Practice Lead Early Commercialisation & Launch at Uptake, shares the 6 key outcomes that define a successful launch. 🎯📈 🎬 Watch the video to discover these crucial outcomes and elevate your pharma launch strategy! -------- ☝️ I am Inge 🔥 My mission: Helping Pharma managers acquire business-critical competencies to make better decisions Liked this post? Want to see more? 🔔 Ring the bell on my Profile to get notified 🔝 Connect with me  #pharma #launchexcellence #launch #pharmamarketing Uptake

Catch the Ostro team in Princeton this Thursday, Nov 14, as Gurjeev Singh, VP of Product, shares how life science brands are adopting strategies from top consumer companies like Netflix and Amazon to deliver seamless, personalized experiences. Learn how pharmaceutical brands are simplifying complex information and enhancing engagement across healthcare. Don’t miss this dive into innovation in life sciences at PanAgora Pharma #CXTECH Summit.

We were privileged to host Mr. Nikkhil K Masurkar, CEO of Entod Pharmaceuticals, as he shared his valuable insights on the topic "Enlighten Your Enterprise: Aligning Philosophy, Spirituality, and Innovation." The session emphasized the importance of integrating philosophical principles and spirituality with business innovation, shedding light on how these elements can drive sustainable growth and ethical decision-making. Mr. Masurkar highlighted the critical role of visionary leadership and adaptability in fostering an enterprise that thrives on purpose and innovation. #BusinessWithPurpose #entod #PhilosophyInBusiness #mba #iim #SpiritualLeadership #pharmaceuticals #InnovateWithIntegrity #healthcare #SustainableGrowth #hospitals #PurposeDrivenEnterprise #BusinessInnovation #AligningValuesAndInnovation

The attached article explain's UpScript's thesis since we created the company more than 20 years ago. Many of the pharma companies mentioned are our partners and it's nice to see them recognized as visionary leaders in direct-to-consumer healthcare.

What’s one thing you’re thankful for in your pharma marketing journey this year? As many of us enter a long weekend, we just want to take a moment to express our gratitude to all the amazing #pharmamarketing leaders and innovators out there! Without your insights, feedback, and creativity, the future of #pharma would be a lot less exciting. #DigiPharma2025 #DigiPharmaConnect2025

Branded vs. Generic: The debate isn’t about quality, it’s about value. Both deliver the same therapeutic effect, but one makes innovation possible while the other makes healthcare affordable. Which do you choose? #Healthcare #Pharma #Innovation #branded #generic #drugs #brandeddrug #genericdrug #Accessibility"#futuredrugmanufacturing #pharmaindustry #Industry40 #Innovation #DigitalTransformation #turnkeysolutions #engineeringconsultancy #projectmanagement #facilitysetup #dozreich #technology #dozreichtechnology #buildingthefuturetoday